Furthermore, TRIM25 enhances tumor cell survival, as treatment with N6F11 to target TRIM25-mediated GPX4 degradation selectively induces cancer cell ferroptosis [17,53,54,55] (Figure 2(Bc)). Here, TRIM25 is linked to neoplasm.